Form 4 for LENZ LENZ Therapeutics, Inc.
Accepted 2021-07-01 00:00:00 ET · period of report 2021-01-13 · accession 0000899243-21-027011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-01 | 2021-06-29 | LENZ | Lehrer-Graiwer Joshua | Pres AND CEO, Dir | C - Cnv Deriv | — | +8,126 | 1.16M | +0.7% | — |
| D | 2021-07-01 | 2021-01-16 | LENZ | Lehrer-Graiwer Joshua | Pres AND CEO, Dir | M - OptEx | $0.3 | +374.0K | 1.15M | +48% | +$112.2K |
| DM | 2021-07-01 | 2021-01-13+ | LENZ | Lehrer-Graiwer Joshua | Pres AND CEO, Dir | A - Grant | $0.0654 | +1.53M | 374.0K | New | +$100.0K |
| D | 2021-07-01 | 2021-01-16 | LENZ | Lehrer-Graiwer Joshua | Pres AND CEO, Dir | M - OptEx | $0.00 | -374.0K | 0 | -100% | $0 |
| D | 2021-07-01 | 2021-06-29 | LENZ | Lehrer-Graiwer Joshua | Pres AND CEO, Dir | C - Cnv Deriv | $0.00 | -19.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-29 | C | A | 8,126 | — | 1,161,670 | D | — | — | (F3) These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date. |
| 2 | Common | Common Stock | 2021-01-16 | M | A | 374,013 | $0.3 | 1,153,544 | D | — | — | (F2) On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. |
| 3 | Derivative | Stock Option (right to buy) | 2021-03-17 | A | A | 340,798 | $0.00 | 340,798 | D | $6.11 · — to 2031-03-16 | 340,798 Common Stock | (F2) On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. (F6) The option was granted subject to the achievement by the Company of performance vesting criteria. On June 29, 2021 the performance vesting criteria was met such that the option became reportable. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| 4 | Derivative | Stock Option (right to buy) | 2021-03-17 | A | A | 795,196 | $0.00 | 795,196 | D | $6.11 · — to 2031-03-16 | 795,196 Common Stock | (F2) On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. (F5) 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| 5 | Derivative | Series B Preferred Stock | 2021-03-11 | A | A | 19,763 | $5.06 | 19,763 | D | — · — to — | 8,126 Common Stock | (F3) These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date. |
| 6 | Derivative | Stock Option (right to buy) | 2021-01-13 | A | A | 374,013 | $0.00 | 374,013 | D | $0.3 · — to 2031-01-12 | 374,013 Common Stock | (F2) On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. (F4) 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after April 20, 2020, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase. |
| 7 | Derivative | Stock Option (right to buy) | 2021-01-16 | M | D | 374,013 | $0.00 | 0 | D | $0.3 · — to 2031-01-12 | 374,013 Common Stock | (F2) On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. (F4) 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after April 20, 2020, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase. |
| 8 | Derivative | Series B Preferred Stock | 2021-06-29 | C | D | 19,763 | $0.00 | 0 | D | — · — to — | 8,126 Common Stock | (F3) These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date. |